Pregled bibliografske jedinice broj: 369716
Prediction of Alzheimer's disease in subjects with mild cognitive impairment using biological markers from CSF
Prediction of Alzheimer's disease in subjects with mild cognitive impairment using biological markers from CSF // Neurologia Croatica 57 (Suppl. 4) / Šimić, Goran ; Mimica, Ninoslav ; Petravić, Damir (ur.).
Zagreb: Denona, 2008. str. 26-26 (pozvano predavanje, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 369716 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Prediction of Alzheimer's disease in subjects with mild cognitive impairment using biological markers from CSF
Autori
Šimić, Goran
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Neurologia Croatica 57 (Suppl. 4)
/ Šimić, Goran ; Mimica, Ninoslav ; Petravić, Damir - Zagreb : Denona, 2008, 26-26
Skup
4th Croatian Congress on Alzheimer's disease with international participation
Mjesto i datum
Rovinj, Hrvatska, 08.10.2008. - 11.10.2008
Vrsta sudjelovanja
Pozvano predavanje
Vrsta recenzije
Domaća recenzija
Ključne riječi
Alzheimer's disease ; amyloid-beta ; cerebrospinal fluid ; dementia ; early diagnosis ; mild cognitive impairment ; tau protein
Sažetak
With the advent of new drugs such as gamma-secretase inhibitors, early detection of elderly subjects with mild cognitive impairment (MCI) who are destined to develop AD is becoming increasingly important. For this purpose, the three most commonly used CSF biomarkers (total tau, amyloid-ß42 protein and phosphorylated tau protein) have been evaluated in numerous studies, including ours. Majority of these investigations confirmed that CSF markers have high sensitivity to differentiate early and incipient AD from normal aging, major depressive disorder, alcoholic dementia and Parkinson’ s disease, but relatively lower specificity against other primary causes of dementia syndrome, such as frontotemporal and Lewy body dementia. In most studies, low amyloid-ß42 and high total tau protein in cerebrospinal fluid were found in about 90% of the MCI cases that progressed to AD as compared with the 10% stable MCI cases. Similarly, higher concentrations of tau protein phosphorylated on threonine 231 were found in MCI cohort that progressed to AD compared to those with stable MCI. It is concluded that pathological levels of two or more CSF markes can reliably predict MCI conversion to AD and correctly identify the stable form of MCI.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Psihologija
POVEZANOST RADA
Projekti:
108-1081870-1942 - Fosforilacija tau proteina u razvitku i Alzheimerovoj bolesti (Šimić, Goran, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Goran Šimić
(autor)